Medicines Australia Welcomes New Chair and members of the Pharmaceutical Benefits Advisory Committee (PBAC)
Medicines Australia is pleased to welcome the appointment of Professor Andrew Wilson as incoming Chair of the Pharmaceutical Benefits Advisory Committee (PBAC).
MA also welcomes the appointments of Dr Peter Grimison and Professor Jonathan Craig as members of the Committee.
“I would like to congratulate all the new members on their appointments,” said Medicines Australia CEO, Tim James.
“Professor Wilson has enormous experience in the health sector and as a former member of PBAC will be well prepared for the demanding role of Chair.
“Medicines Australia looks forward to a collaborative, pragmatic and patient focused PBAC under Professor Wilson’s stewardship.
“He has shown a willingness to engage with the medicines industry and has a deep understanding of the issues impacting on our sector.
“Medicines Australia welcomes the reforms to the PBAC proposed by the Health Minister Sussan Ley, which include an expansion of membership and streamlining of operations to help with the increased volume and complexity of the Committee’s work.
“We look forward to understanding the detail of these reforms as it becomes available and to working with the Minister to ensure an efficient, streamlined process.
“We want to work with the PBAC towards what should be our shared priority, namely, the timely listing of new, innovative and cost-effective medicines to the Pharmaceutical Benefits Scheme (PBS).”
Phone: 0423 239 265